Juergen Dukart received the Diploma degree in psychology from Ruhr University Bochum, in 2008, and the Ph.D. degree in neuroscience from the Max Planck Institute for Human Cognitive and Brain Sciences, in 2011. He was a Postdoctoral Researcher at the University of Lausanne, Switzerland. Then, he moved to the Pharmaceutical Company F. Hoffmann-La Roche, where he worked for five years in different functions, such as the Head of Clinical Imaging and a Biomarker Experimental Medicine Leader being responsible for imaging and overall biomarker strategy in various phase I to phase III clinical trials. Since 2019, he has been leading the Group Biomarker Development, Institute of Neuroscience and Medicine (INM-7), Research Centre Jülich, Germany. He is the author of more than 60 articles. His main research interests include the development of technology-based biomarkers for early detection, follow-up, stratification, and monitoring of treatment effects in neurological and psychiatric diseases. He is an Associate Editor of the journal Frontiers in Human Neuroscience.